Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 77 (RPL7AP77) is a human pseudogene located on chromosome 7[3][8][4]. As a pseudogene, it is a DNA sequence that closely resembles the functional ribosomal protein L7a gene but has lost the ability to code for a protein, often due to mutations or lack of necessary regulatory elements[10]. Pseudogenes in general may have regulatory functions in gene expression via RNA-mediated mechanisms but do not encode functional proteins and are not conventional drug or therapeutic targets[6][10]. There is no evidence of physiological function, disease association, or drug interaction for RPL7AP77 as of current genome annotation[3][4][8][9]. RPL7AP77 should not be considered a therapeutic target; it is a noncoding pseudogene with no well-described biological function, clinical relevance, or drug interactions.[3][10]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 77 (RPL7AP77).